The Cannabis Trade: An Industry Set to Take Off (w/ Jason Wild and Tony Greer)

The Cannabis Trade: An Industry Set to Take O...

Up next

We're Not Ready For This

The Exponential Age is here, and it's accelerating — bringing developments humanity is simply not ready for. In a special crossover episode of The Journey Man and the Exponentialist, Raoul Pal sits down with David Mattin, technology lead at GMI, for a deep dive into the world of ...  Show more

Trading the Markets with AI: March 4, 2026

Kris Bullock joins Bijan Maleki to break down how traders can use AI to level up their process. Whether through enhanced research, coding apps and dashboards, or creating technical indicators, Kris covers it all with a rotating cast of RV community members. Tune in live every Wed ...  Show more

Recommended Episodes

Cannabis Stocks: Keep It Simple
The Cannabis Investing Podcast

After decades of long/short equity investing for hedge funds on the sell side, Mike Regan switched to covering the cannabis space for MJBizDaily. He joins Rena Sherbill to discuss the similarities between the internet bubble and the cannabis market today and what we can glean fro ...  Show more

Cannabis Marketing
Under the Influence with Terry O'Reilly

This week, we go one toke over the line and look at the emerging world of cannabis marketing.We start with the question - just how does a plant become illegal?We’ll explore the history of cannabis.We’ll talk about which celebrities have their own brands (Hello Willie Nelson!)Whic ...  Show more

How a Global Brewing Company Explored the Cannabis Market
HBR On Strategy

Innovation is a challenge for large incumbent companies. Their long-term success depends on exploring new innovations that stretch the organization beyond its core businesses. But these new opportunities must draw on the company’s existing strengths and leadership position. Harva ...  Show more

GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)
The Tape

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades. Learn more about your ad-choices at https://www ...  Show more